885520-14-9

Basic information

• Product Name: 4-nitro-6-fluoroindazole
• Synonyms: 4-nitro-6-fluoroindazole;1H-indazole, 6-fluoro-4-nitro-;6-Fluoro-4-nitro-1H-indazole
• CAS NO: 885520-14-9
• Molecular Formula: C7H4FN3O2
• Molecular Weight: 181.1239632
• Mol File: 885520-14-9.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Density: 1.629
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-nitro-6-fluoroindazole(CAS DataBase Reference)
• NIST Chemistry Reference: 4-nitro-6-fluoroindazole(885520-14-9)
• EPA Substance Registry System: 4-nitro-6-fluoroindazole(885520-14-9)

Safety Data

• Hazardous Substances Data: 885520-14-9(Hazardous Substances Data)

Usage

General Description

4-nitro-6-fluoroindazole is a chemical compound with the molecular formula C7H4FN3O2. It is an indazole derivative with a nitro and a fluoro group attached to the benzene ring. 4-nitro-6-fluoroindazole has been studied for its potential pharmaceutical applications, particularly in the field of medicinal chemistry where it is being investigated for its potential use as an antitumor agent and as an anti-inflammatory drug. Its unique structure and functional groups make it a promising candidate for further research and development in the pharmaceutical industry. However, its use and handling should be done in accordance with appropriate safety measures due to its potentially hazardous properties.

Upstream product

• 352-32-9 p-fluorotoluene 
• 102735-88-6 5-fluoro-2-methyl-1,3-dinitrobenzene 
• 446-10-6 2-nitro-4-fluorotoluene 
• 168770-44-3 5-fluoro-2-methyl-3-nitroaniline 

Downstream Products

• 1058142-18-9 ethyl 6-fluoro-4[(phenoxycarbonyl)amino]-1H-indazole-1-carboxylate 

Relevant articles and documents

Indazole compounds and application thereof to preparation of IDO inhibitors

The invention discloses indazole compounds as shown in a formula (i) or (II) which is described in the specification, and a preparation method thereof, and application of the compounds as IDO inhibitors. The compounds provided by the invention can be used for preventing and/or treating a plurality of diseases, such as Alzheimer's disease, cataract, infections related to cellular immune activation,autoimmune diseases, AIDS, cancers, depression, the metabolic disorder of tryptophan or the like.

MINERALOCORTICOID RECEPTOR ANTAGONISTS

The present invention is directed to compounds of the Formula I: as well as pharmaceutically acceptable salts thereof, that may be useful for treating aldosterone-mediated diseases. The invention furthermore relates to specific diastereomers and enantiome

INDAZOLE DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS

The present invention relates to indazole derivatives of the following formula I, which can be used as vanilloid receptor ligands, processes for their preparation, and their use in treating diseases, conditions and/or disorders modulated by vanilloid receptors. (I)